Fennec Pharmaceuticals Inc. SEC filings FENC

Fennec Pharmaceuticals Inc. has 853 filings in SEC EDGAR's recent list, going back to Dec 10, 2002. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (other events). The company's fiscal year ends on December 31.

Fennec Pharmaceuticals Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 2, 2026 Oct 31, 2026
4 Insider transaction Nov 2, 2026 Oct 31, 2026
4 Insider transaction Nov 2, 2026 Oct 31, 2026
4 Insider transaction Nov 2, 2026 Oct 31, 2026
4 Insider transaction Nov 2, 2026 Oct 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 19, 2026 —
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
8-K Current report
Other events
Sep 17, 2026 Sep 17, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 31, 2026 Aug 31, 2026
144 Notice of proposed sale Aug 31, 2026 —
4 Insider transaction Aug 28, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
4 Insider transaction Aug 4, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Aug 3, 2026 Jul 31, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 1, 2026 —
S-8 Employee stock plan registration Jun 11, 2026 —
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 2, 2026 May 31, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction Jun 1, 2026 May 31, 2026
4 Insider transaction Jun 1, 2026 May 31, 2026
8-K Current report
Other events
May 22, 2026 May 21, 2026
8-K Current report
Officer or director change
May 18, 2026 May 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 12, 2026 May 11, 2026
144 Notice of proposed sale May 11, 2026 —
4 Insider transaction May 1, 2026 Apr 30, 2026
144 Notice of proposed sale May 1, 2026 —
4 Insider transaction May 1, 2026 Apr 30, 2026
4 Insider transaction May 1, 2026 Apr 30, 2026
4 Insider transaction May 1, 2026 Apr 30, 2026
4 Insider transaction May 1, 2026 Apr 30, 2026
4 Insider transaction May 1, 2026 Apr 30, 2026
8-K Current report
Officer or director change
Apr 28, 2026 Apr 27, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 10, 2026
8-K Current report
Other events
Apr 22, 2026 Apr 22, 2026
8-K Current report
Other events
Apr 7, 2026 Apr 7, 2026
4 Insider transaction Apr 2, 2026 Mar 28, 2026
4 Insider transaction Apr 2, 2026 Mar 28, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 28, 2026
4 Insider transaction Apr 2, 2026 Mar 28, 2026
4 Insider transaction Apr 2, 2026 Mar 28, 2026
144 Notice of proposed sale Apr 1, 2026 —
10-K Annual report Mar 27, 2026 Dec 31, 2025
4 Insider transaction Mar 26, 2026 Mar 26, 2026
4 Insider transaction Mar 26, 2026 Mar 26, 2026
8-K Current report
Results of operations
Mar 24, 2026 Mar 24, 2026
8-K Current report
Other events
Mar 16, 2026 Mar 16, 2026
S-8 Employee stock plan registration Mar 5, 2026 —
8-K Current report
Other events
Mar 4, 2026 Mar 4, 2026
4 Insider transaction Mar 3, 2026 Feb 28, 2026
4 Insider transaction Mar 3, 2026 Feb 28, 2026
144 Notice of proposed sale Mar 2, 2026 —
8-K Current report
Other events
Feb 20, 2026 Feb 20, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
4 Insider transaction Feb 2, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Feb 2, 2026 Jan 31, 2026
4 Insider transaction Feb 2, 2026 Jan 31, 2026
4 Insider transaction Jan 23, 2026 Jan 23, 2026
4 Insider transaction Jan 15, 2026 Jan 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 14, 2026 —
4 Insider transaction Jan 7, 2026 Jan 7, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 29, 2025 Dec 24, 2025
8-K Current report
Other events
Dec 9, 2025 Dec 9, 2025
4 Insider transaction Dec 5, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 5, 2025 —
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
8-K Current report
Other events
Dec 2, 2025 Dec 2, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
8-K Current report
Material agreement, Other events
Nov 19, 2025 Nov 13, 2025
S-8 Employee stock plan registration Nov 18, 2025 —
8-K Current report
Material agreement, Other events
Nov 18, 2025 Nov 17, 2025
424B5 Prospectus supplement Nov 18, 2025 —
4 Insider transaction Nov 17, 2025 Nov 14, 2025
424B5 Prospectus supplement Nov 17, 2025 —
8-K Current report
Material agreement, Other events
Nov 17, 2025 Nov 13, 2025
424B5 Prospectus supplement Nov 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 3, 2025 Oct 31, 2025
4 Insider transaction Nov 3, 2025 Oct 31, 2025
4 Insider transaction Oct 14, 2025 Oct 10, 2025
144 Notice of proposed sale Oct 10, 2025 —
4 Insider transaction Oct 9, 2025 Oct 7, 2025
4 Insider transaction Oct 8, 2025 Oct 8, 2025
4 Insider transaction Oct 6, 2025 Oct 6, 2025
144 Notice of proposed sale Oct 6, 2025 —
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Sep 8, 2025 Sep 5, 2025
144 Notice of proposed sale Sep 4, 2025 —
4 Insider transaction Sep 4, 2025 Sep 4, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
4 Insider transaction Sep 2, 2025 Aug 31, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
4 Insider transaction Aug 5, 2025 Aug 5, 2025
144 Notice of proposed sale Aug 5, 2025 —
4 Insider transaction Aug 1, 2025 Jul 31, 2025
4 Insider transaction Aug 1, 2025 Jul 31, 2025
4 Insider transaction Jul 7, 2025 Jul 7, 2025
4 Insider transaction Jul 7, 2025 Jul 3, 2025
144 Notice of proposed sale Jul 3, 2025 —
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
144 Notice of proposed sale Jun 5, 2025 —
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
8-K Current report
Shareholder vote results
Jun 3, 2025 Jun 3, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 19, 2025 May 16, 2025
4 Insider transaction May 19, 2025 May 16, 2025
4 Insider transaction May 19, 2025 May 16, 2025
144 Notice of proposed sale May 16, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
4 Insider transaction May 5, 2025 May 5, 2025
144 Notice of proposed sale May 5, 2025 —
4 Insider transaction May 1, 2025 Apr 30, 2025
4 Insider transaction May 1, 2025 Apr 30, 2025
DEF 14A Proxy statement Apr 25, 2025 Jun 3, 2025
4 Insider transaction Apr 11, 2025 Apr 11, 2025
4 Insider transaction Apr 4, 2025 Apr 4, 2025
144 Notice of proposed sale Apr 4, 2025 —
4/A Filing Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 3, 2025 Mar 28, 2025
4/A Filing Apr 3, 2025 Mar 28, 2025
4/A Filing Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 3, 2025 Mar 28, 2025
4 Insider transaction Apr 1, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Mar 31, 2025
10-K Annual report Mar 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
4 Insider transaction Mar 6, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Feb 28, 2025 Feb 28, 2025
4 Insider transaction Feb 28, 2025 Feb 28, 2025
4 Insider transaction Feb 14, 2025 Feb 14, 2025
144 Notice of proposed sale Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
FENC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Research Triangle Park, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1211583
Former names
ADHEREX TECHNOLOGIES INC (until Aug 14, 2014)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.